- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
46 Dementia Trials near Plymouth, IN
Power is an online platform that helps thousands of Dementia patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerKarXT + KarX-EC for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
586 Participants Needed
Speech-Language Therapy for Primary Progressive Aphasia
Trial Details
Key Eligibility Criteria
200 Participants Needed
Online Program for Dementia Caregiver Burden
Trial Details
Key Eligibility Criteria
140 Participants Needed
KarXT + KarX-EC for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
586 Participants Needed
Improvised Music for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
30 Participants Needed
Tau PET Imaging for Primary Progressive Aphasia
Trial Details
Key Eligibility Criteria
70 Participants Needed
Screening for Alzheimer's Disease Studies
Trial Details
Key Eligibility Criteria
13000 Participants Needed
JNJ-63733657 for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
523 Participants Needed
Sensory Stimulation for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
670 Participants Needed
Donanemab for Early Alzheimer's Disease
Trial Details
Key Eligibility Criteria
1736 Participants Needed
Remternetug for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
1667 Participants Needed
Remternetug for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
280 Participants Needed
Gantenerumab for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
280 Participants Needed
Investigational Alzheimer's Drugs for Early Onset Alzheimer's Disease
Trial Details
Key Eligibility Criteria
197 Participants Needed
Disease-Modifying Drugs for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
490 Participants Needed
Motion-Based Activities for Dementia
Trial Details
Key Eligibility Criteria
20 Participants Needed
Why Other Patients Applied
"I watched my mother die from Parkinson’s. At the time of her death, she weighed 85 pounds and could not move any muscles voluntarily except her eyelids. I would like to participate in a trial to help find a better treatment for PD than what is currently available. It is a devastating illness. It breaks my heart that other families will have to go through this."
"I have a very strong family history of Alzheimer’s, with my maternal grandmother, mother, uncle, and sister having the disease. My APOE status is 2/4. My memory is going, although 6 months ago I tested decently on some cognitive tests. I'd like to help myself by getting ahead of my condition and help others in a similar situation by participating in medical research."
"I'm so used to losing things, forgetting things, making up to acronyms to remember things only to remember the acromym but not what the letters stand for... I enter a new room to look for an item, only to forget what I was looking for. I've discussed the existing treatments with my neurologist and she's on board with my joining a clinical trial."
"I have been on standard Alzheimer's medication for a few years but know this treatment only works to delay my cognitive deterioration, not improve it. I've been doing research, which brought me here, to consider some of the latest research drugs. While I know that there's no guarantee that a clinical trial improves my condition, I'd like to give one a try and help further the research for all."
"I watched my mother suffer through years of Alzheimer's Disease and I want to help advance the science for treating AD. I don't want anyone else to have go through what our family went through."
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Dementia clinical trials in Plymouth, IN pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Dementia clinical trials in Plymouth, IN work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Dementia trials in Plymouth, IN 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Plymouth, IN for Dementia is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Plymouth, IN several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Dementia medical study in Plymouth, IN?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Dementia clinical trials in Plymouth, IN?
Most recently, we added KarXT + KarX-EC for Alzheimer's Disease, KarXT + KarX-EC for Alzheimer's Disease and Online Program for Dementia Caregiver Burden to the Power online platform.